BlackRock »

Citius Oncology shares owned by BlackRock

Quarter-by-quarter ownership of Citius Oncology (CTOR) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Citius Oncology

Tip: Access up to 7 years of quarterly data

All positions including Citius Oncology held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Oncology by BlackRock

Quarter filed Position value Share count Share price at filing
2025-12-31 $22k 22k 1.00

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)

View all positions for BlackRock

Top funds holding Citius Oncology

Armistice Capital
Vanguard Group
Geode Capital Management
OMERS Administration Corporation
IFP Advisors
XTX Topco
Northern Trust
State Street Corporation
BlackRock
UBS Group
Citadel Advisors
Two Sigma Securities
Arkadios Wealth Advisors
Advisor Group Holdings
Versant Capital Management

View all funds holding Citius Oncology